109 related articles for article (PubMed ID: 17328979)
1. Economic evaluation of services for a National Health scheme: the case for a fairness-based framework.
Richardson J; McKie J
J Health Econ; 2007 Jul; 26(4):785-99. PubMed ID: 17328979
[TBL] [Abstract][Full Text] [Related]
2. Inequalities and healthcare reform in Chile: equity of what?
Burrows J
J Med Ethics; 2008 Sep; 34(9):e13. PubMed ID: 18757613
[TBL] [Abstract][Full Text] [Related]
3. Social preferences for the inclusion of indirect benefits in the evaluation of publicly funded health services: results from an Australian survey.
McKie J; Richardson J
Health Econ Policy Law; 2011 Oct; 6(4):449-68. PubMed ID: 21819634
[TBL] [Abstract][Full Text] [Related]
4. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
5. [Prinicipal health services accessibility risks in the European Union countries].
Moradell M; Halley des Fontaines V
Sante Publique; 2000 Dec; 12(4):513-27. PubMed ID: 11349337
[TBL] [Abstract][Full Text] [Related]
6. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
Richardson JR; Olsen JA
Health Econ; 2006 Mar; 15(3):311-3; discussion 319-22. PubMed ID: 16389655
[TBL] [Abstract][Full Text] [Related]
7. Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting?
Gibson J; Mitton C; Martin D; Donaldson C; Singer P
J Health Serv Res Policy; 2006 Jan; 11(1):32-7. PubMed ID: 16378530
[TBL] [Abstract][Full Text] [Related]
8. [Lenin and the contract physician].
Gebauer CA
Chirurg; 2006 Jun; Suppl():169-73. PubMed ID: 17855919
[No Abstract] [Full Text] [Related]
9. Framework for assessing governance of the health system in developing countries: gateway to good governance.
Siddiqi S; Masud TI; Nishtar S; Peters DH; Sabri B; Bile KM; Jama MA
Health Policy; 2009 Apr; 90(1):13-25. PubMed ID: 18838188
[TBL] [Abstract][Full Text] [Related]
10. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
11. An economic analysis of the national shared Emergency Care Summary in Scotland.
Jones T; Dobrev A; Cameron J; Morris L; Stroetmann KA; Stroetmann VN
J Telemed Telecare; 2009; 15(3):129-31. PubMed ID: 19364894
[TBL] [Abstract][Full Text] [Related]
12. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
Abramowitz S; Greene D
AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
[TBL] [Abstract][Full Text] [Related]
13. Core drivers of quality: a remote health example from Australia.
Burley MB; Greene P
Rural Remote Health; 2007; 7(3):611. PubMed ID: 17691857
[TBL] [Abstract][Full Text] [Related]
14. Review of small rural health services in Victoria: how does the nursing-medical division of labour affect access to emergency care?
Sullivan E; Francis K; Hegney D
J Clin Nurs; 2008 Jun; 17(12):1543-52. PubMed ID: 18482116
[TBL] [Abstract][Full Text] [Related]
15. [Schizophrenic patients' length of stay: mental health care implication and medicoeconomic consequences].
Capdevielle D; Boulenger JP; Villebrun D; Ritchie K
Encephale; 2009 Sep; 35(4):394-9. PubMed ID: 19748377
[TBL] [Abstract][Full Text] [Related]
16. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences.
Adhikari SR; Maskay NM; Sharma BP
Health Policy Plan; 2009 Mar; 24(2):129-39. PubMed ID: 19181674
[TBL] [Abstract][Full Text] [Related]
17. 'Fair benefits' accounts of exploitation require a normative principle of fairness: response to Gbadegesin and Wendler, and Emanuel et al.
Ballantyne A
Bioethics; 2008 May; 22(4):239-44. PubMed ID: 18405322
[TBL] [Abstract][Full Text] [Related]
18. Excess capacity and expense preference behaviour in National Health Systems: an application to the Spanish public hospitals.
RodrÃguez-Alvarez A; Knox Lovell CA
Health Econ; 2004 Feb; 13(2):157-69. PubMed ID: 14737753
[TBL] [Abstract][Full Text] [Related]
19. Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.
Drummond M; Evans B; LeLorier J; Karakiewicz P; Martin D; Tugwell P; MacLeod S
Can J Clin Pharmacol; 2009; 16(2):e273-81; discussion e282-4. PubMed ID: 19439771
[TBL] [Abstract][Full Text] [Related]
20. [The development of the public health system between an increasing market orientation (commercialisation) and social responsibility].
Trabert G
Zentralbl Chir; 2008 Feb; 133(1):39-45. PubMed ID: 18278701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
